Ronald Thibert, DO, MsPH is a Pediatric Epileptologist with a interest in the treatment of epilepsy in children with autistic spectrum disorders. He is the director of the Angelman Syndrome Clinic and the Dup15q Center for MGHfC and the Lurie Center.
Dr. Thibert received his B.S. in biology/psychology from the University of Notre Dame in 1994 and his MsPH in Epidemiology from the University of Massachusetts School of Public Health in 1996. After graduating from KCUMB in 2000, he did his Pediatric training at Henry Ford Hospital from 2000-2003, followed by his Pediatric Neurology training at the Floating Hospital and Children's Hospital Boston from 2003-2006. He then completed a fellowship in Pediatric Epilepsy/Clinical Neurophysiology at MGH from 2006-2008 and remains on staff there in the Pediatric Epilepsy Program. He is also on the faculty at Harvard Medical School.
Dr. Thibert has a special interest in the treatment of epilepsy and epileptic encephalopathies in children with autistic spectrum disorders. He sees children and young adults with autistic spectrum disorders and epilepsy at the Lurie Center and, if indicated, performs long-term EEG monitoring at MGHfC as part of the diagnostic process. A full range of treatment options including dietary therapy for epilepsy is available.
Dr. Thibert is the Director of the Angelman Syndrome clinic and MGHfC/Lurie Center and is on the Scientific Advisory Committee of the Angelman Syndrome Foundation. He is also the Director of the Dup15q Center at MGHfC/Lurie Center and is on the Professional Advisory Board of the Dup15q Alliance.
Ronald Thibert, DO, MsPH is a pediatric epileptologist in the Pediatric Epilepsy Program at MGHfC and the Lurie Center for Autism, specializing in the treatment of children with difficult to control seizures. He has a special interest in children with autistic spectrum disorders, especially those with Angelman syndrome and duplications of chromosome 15q (Dup15q). He is the director of both the Angelman syndrome clinic and the Dup15q Center at MGHfC and the Lurie Center and the majority of his clinical research focuses on the treatment of seizures in these 2 genetic disorders.
MassGeneral Hospital for Children will soon open the world’s first Pitt Hopkins Syndrome Clinic. Made possible by a generous donation from parents of two young women with Pitt Hopkins Syndrome, the clinic will focus on providing knowledge-based medical care and serving the comprehensive medical needs of individuals with the disease.
The Angelman Syndrome Clinic, one of only two in the country, will work to reduce the frequency and severity of Angelman syndrome symptoms, particularly seizures, and to develop dietary regimens for individuals that further assist in the reduction of symptoms.
The Pitt Hopkins Syndrome Clinic will work with patients and families to further understand, diagnose, and treat Pitt Hopkins Syndrome, a rare genetic disorder.